Umeclidinium bromide vs placebo
Hospitalisations due to COPD exacerbations · patients with chronic obstructive pulmonary disease
Umeclidinium bromide showed no clear difference in number of participants with hospital admissions due to COPD… compared with placebo (low certainty).
1 finding from 1 review
- Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD) 2017 · Cochrane Headline outcomes onlyOR 0.86 [0.25, 2.92]4 studies · 1922 participantsLow